Fenofibrate Patent Expiration
Fenofibrate is Used for managing high levels of cholesterol and triglycerides in the blood. It was first introduced by Abbvie Inc
Fenofibrate Patents
Given below is the list of patents protecting Fenofibrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Antara (micronized) | US7101574 | Pharmaceutical composition containing fenofibrate and the preparation method |
Aug 20, 2020
(Expired) | Lupin |
| Antara (micronized) | US7863331 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
Aug 08, 2020
(Expired) | Lupin |
| Antara (micronized) | US8026281 | Treating metabolic syndrome with fenofibrate | Apr 22, 2025 | Lupin |
| Antara (micronized) | US9314447 | Reduced dose pharmaceutical compositions of fenofibrate | May 31, 2033 | Lupin |
| Fenoglide | US7658944 | Solid dosage form comprising a fibrate | Dec 09, 2024 | Salix |
| Fenoglide | US8124125 | Solid dosage form comprising a fibrate | Oct 01, 2024 | Salix |
| Fenoglide | US8481078 | Solid dosage form comprising a fibrate | Oct 01, 2024 | Salix |
| Fenoglide | US9173847 | Tablet comprising a fibrate | Oct 01, 2024 | Salix |
| Lipofen | US5545628 | Pharmaceutical composition containing fenofibrate |
Jan 10, 2015
(Expired) | Cipher Pharms Inc |
| Tricor | US6074670 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US6277405 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US6375986 | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
Sep 21, 2020
(Expired) | Abbvie |
| Tricor | US6589552 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US6652881 | Fenofibrate pharmaceutical composition having high bioavailability |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US7037529 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US7041319 | Fenofibrate pharmaceutical composition having high bioavailabilty |
Jan 09, 2018
(Expired) | Abbvie |
| Tricor | US7276249 | Nanoparticulate fibrate formulations |
Feb 21, 2023
(Expired) | Abbvie |
| Tricor | US7320802 | Methods of treatment using nanoparticulate fenofibrate compositions |
Feb 21, 2023
(Expired) | Abbvie |
| Triglide | US6696084 | Spray drying process and compositions of fenofibrate |
Sep 11, 2021
(Expired) | Skyepharma Ag |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fenofibrate's patents.
Latest Legal Activities on Fenofibrate's Patents
Given below is the list recent legal activities going on the following patents of Fenofibrate.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Jul, 2019 | US7320802(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Apr, 2019 | US7276249(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Oct, 2017 | US7037529(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Oct, 2017 | US7041319(Litigated) |
| File Marked Found | 18 Apr, 2016 | US6652881 |
| File Marked Found | 18 Apr, 2016 | US6589552(Litigated) |
| File Marked Found | 07 Apr, 2016 | US6589552(Litigated) |
| File Marked Found | 07 Apr, 2016 | US6652881 |
| File Marked Found | 05 Apr, 2016 | US6589552(Litigated) |
| File Marked Found | 05 Apr, 2016 | US6652881 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Fenofibrate Generics
Several generic applications have been filed for Fenofibrate. The first generic version for Fenofibrate was by Rhodes Pharmaceuticals Lp and was approved on Apr 9, 2002. And the latest generic version is by Yichang Humanwell Pharmaceutical Co Ltd and was approved on Apr 24, 2024.
Given below is the list of companies who have filed for Fenofibrate generic.
1. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Aug 17, 2018 |
| 160MG | tablet | Prescription | ORAL | AB | Aug 17, 2018 |
| 145MG | tablet | Prescription | ORAL | AB | Mar 18, 2020 |
| 48MG | tablet | Prescription | ORAL | AB | Mar 18, 2020 |
2. AMNEAL
Amneal Pharmaceuticals Llc has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Feb 9, 2018 |
| 48MG | tablet | Prescription | ORAL | AB | Feb 9, 2018 |
| 160MG | tablet | Prescription | ORAL | AB | Mar 19, 2018 |
| 54MG | tablet | Prescription | ORAL | AB | Mar 19, 2018 |
3. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Discontinued | ORAL | N/A | Mar 28, 2017 |
| 200MG | capsule | Discontinued | ORAL | N/A | Mar 28, 2017 |
| 67MG | capsule | Discontinued | ORAL | N/A | Mar 28, 2017 |
4. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Jul 12, 2016 |
| 145MG | tablet | Prescription | ORAL | AB | Jul 12, 2016 |
5. IMPAX LABS
Impax Laboratories Inc has filed for 5 different strengths of generic version for Fenofibrate. Out of these 200mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED), 134mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule | Discontinued | ORAL | N/A | Oct 27, 2003 |
| 67MG | capsule | Discontinued | ORAL | N/A | Oct 27, 2003 |
| 134MG | capsule | Discontinued | ORAL | N/A | Oct 27, 2003 |
| 160MG
(reference standard) | tablet | Prescription | ORAL | AB | Mar 26, 2008 |
| 54MG | tablet | Prescription | ORAL | AB | Mar 26, 2008 |
6. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG
(reference standard) | tablet | Prescription | ORAL | AB | May 5, 2016 |
| 48MG | tablet | Prescription | ORAL | AB | May 5, 2016 |
| 160MG | tablet | Prescription | ORAL | AB | Sep 27, 2022 |
| 54MG | tablet | Prescription | ORAL | AB | Sep 27, 2022 |
7. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 130MG | capsule | Prescription | ORAL | AB | Jul 26, 2013 |
| 43MG | capsule | Prescription | ORAL | AB | Jul 26, 2013 |
8. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Fenofibrate. Out of these 200mg version comes by the name FENOFIBRATE (MICRONIZED), 134mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Aug 9, 2019 |
| 145MG | tablet | Prescription | ORAL | AB | Aug 9, 2019 |
| 54MG | tablet | Discontinued | ORAL | N/A | Jan 17, 2020 |
| 160MG | tablet | Discontinued | ORAL | N/A | Jan 17, 2020 |
| 200MG | capsule | Prescription | ORAL | AB | Oct 19, 2020 |
| 134MG | capsule | Prescription | ORAL | AB | Oct 19, 2020 |
| 67MG | capsule | Prescription | ORAL | AB | Oct 19, 2020 |
9. TORRENT
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Jun 26, 2018 |
| 200MG | capsule | Prescription | ORAL | AB | Jun 26, 2018 |
| 67MG | capsule | Prescription | ORAL | AB | Jun 26, 2018 |
10. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Dec 15, 2016 |
| 145MG | tablet | Prescription | ORAL | AB | Dec 15, 2016 |
11. MANKIND PHARMA
Mankind Pharma Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Jun 12, 2020 |
| 160MG | tablet | Prescription | ORAL | AB | Jun 12, 2020 |
12. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Dec 23, 2011 |
| 145MG | tablet | Prescription | ORAL | AB | Dec 23, 2011 |
| 160MG | tablet | Prescription | ORAL | AB | Aug 17, 2015 |
| 54MG | tablet | Prescription | ORAL | AB | Aug 17, 2015 |
13. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 107MG | tablet | Prescription | ORAL | N/A | Oct 31, 2005 |
| 54MG | tablet | Prescription | ORAL | AB | Oct 31, 2005 |
| 160MG | tablet | Prescription | ORAL | AB | Oct 31, 2005 |
| 130MG | capsule | Prescription | ORAL | AB | Oct 31, 2014 |
| 43MG | capsule | Prescription | ORAL | AB | Oct 31, 2014 |
14. VALEANT PHARMS NORTH
Valeant Pharmaceuticals North America Llc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Valeant Pharms North.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 48MG | tablet | Prescription | ORAL | AB | Apr 5, 2012 |
| 145MG | tablet | Prescription | ORAL | AB | Apr 5, 2012 |
15. CREEKWOOD PHARMS
Creekwood Pharmaceuticals Llc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Creekwood Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | BX | Sep 7, 2023 |
| 120MG | tablet | Prescription | ORAL | BX | Sep 7, 2023 |
16. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 130MG | capsule | Prescription | ORAL | AB | Mar 1, 2012 |
| 43MG | capsule | Prescription | ORAL | AB | Mar 1, 2012 |
17. AUSTARPHARMA
Austarpharma Llc has filed for 4 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Austarpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Dec 19, 2017 |
| 160MG | tablet | Prescription | ORAL | AB | Dec 19, 2017 |
| 145MG | tablet | Prescription | ORAL | AB | Feb 10, 2021 |
| 48MG | tablet | Prescription | ORAL | AB | Feb 10, 2021 |
18. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 160MG | tablet | Prescription | ORAL | AB | Feb 11, 2019 |
| 54MG | tablet | Prescription | ORAL | AB | Feb 11, 2019 |
19. CHARTWELL
Chartwell Life Molecules Llc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Chartwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule | Prescription | ORAL | AB | Jan 31, 2024 |
| 67MG | capsule | Prescription | ORAL | AB | Jan 31, 2024 |
| 134MG | capsule | Prescription | ORAL | AB | Jan 31, 2024 |
20. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 5 different strengths of generic version for Fenofibrate. Out of these 200mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED), 134mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Jul 23, 2018 |
| 160MG | tablet | Prescription | ORAL | AB | Jul 23, 2018 |
| 200MG
(reference standard) | capsule | Prescription | ORAL | AB | Sep 10, 2018 |
| 67MG | capsule | Prescription | ORAL | AB | Sep 10, 2018 |
| 134MG | capsule | Prescription | ORAL | AB | Sep 10, 2018 |
21. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Aug 28, 2018 |
| 48MG | tablet | Prescription | ORAL | AB | Aug 28, 2018 |
22. RHODES PHARMS
Rhodes Pharmaceuticals Lp has filed for 5 different strengths of generic version for Fenofibrate. Out of these 134mg version comes by the name FENOFIBRATE (MICRONIZED), 200mg version comes by the name FENOFIBRATE (MICRONIZED), 67mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Rhodes Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Apr 9, 2002 |
| 200MG | capsule | Prescription | ORAL | AB | Apr 9, 2002 |
| 67MG | capsule | Prescription | ORAL | AB | Sep 3, 2002 |
| 160MG | tablet | Prescription | ORAL | AB | May 13, 2005 |
| 54MG | tablet | Prescription | ORAL | AB | May 13, 2005 |
23. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 67MG | capsule | Prescription | ORAL | AB | Apr 7, 2017 |
| 134MG | capsule | Prescription | ORAL | AB | Apr 7, 2017 |
| 200MG | capsule | Prescription | ORAL | AB | Apr 7, 2017 |
24. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 107MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2005 |
| 160MG | tablet | Prescription | ORAL | AB | Oct 25, 2007 |
| 54MG | tablet | Prescription | ORAL | AB | Oct 25, 2007 |
25. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Fenofibrate. Out of these 130mg version comes by the name FENOFIBRATE (MICRONIZED), 43mg version comes by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Dec 7, 2012 |
| 48MG | tablet | Prescription | ORAL | AB | Dec 7, 2012 |
| 130MG | capsule | Discontinued | ORAL | N/A | Jan 10, 2013 |
| 43MG | capsule | Discontinued | ORAL | N/A | Jan 10, 2013 |
| 40MG | tablet | Prescription | ORAL | AB | Jun 23, 2016 |
| 120MG
(reference standard) | tablet | Prescription | ORAL | AB | Jun 23, 2016 |
26. DR REDDYS
Dr Reddys Laboratories Inc has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
| 160MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
27. RISING
Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 67MG | capsule | Discontinued | ORAL | N/A | Oct 23, 2012 |
| 200MG | capsule | Discontinued | ORAL | N/A | Oct 23, 2012 |
| 134MG | capsule | Discontinued | ORAL | N/A | Oct 23, 2012 |
28. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Apr 30, 2018 |
| 200MG | capsule | Prescription | ORAL | AB | Apr 30, 2018 |
| 67MG | capsule | Prescription | ORAL | AB | Apr 30, 2018 |
29. YICHANG HUMANWELL
Yichang Humanwell Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 54MG | tablet | Prescription | ORAL | AB | Apr 24, 2024 |
| 160MG | tablet | Prescription | ORAL | AB | Apr 24, 2024 |
30. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 134MG | capsule | Prescription | ORAL | AB | Sep 20, 2021 |
| 67MG | capsule | Prescription | ORAL | AB | Sep 20, 2021 |
| 200MG | capsule | Prescription | ORAL | AB | Sep 20, 2021 |
31. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Fenofibrate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 145MG | tablet | Prescription | ORAL | AB | Sep 7, 2017 |
| 48MG | tablet | Prescription | ORAL | AB | Sep 7, 2017 |
32. NOVAST LABS
Novast Laboratories Ltd has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 67MG | capsule | Discontinued | ORAL | N/A | Apr 19, 2019 |
| 134MG | capsule | Discontinued | ORAL | N/A | Apr 19, 2019 |
| 200MG | capsule | Discontinued | ORAL | N/A | Apr 19, 2019 |
33. REYOUNG
Reyoung Corporation has filed for 3 different strengths of generic version for Fenofibrate. All of these versions come by the name FENOFIBRATE (MICRONIZED). Given below are the details of the strengths of this generic introduced by Reyoung.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 67MG | capsule | Prescription | ORAL | AB | Nov 16, 2017 |
| 134MG | capsule | Prescription | ORAL | AB | Nov 16, 2017 |
| 200MG | capsule | Prescription | ORAL | AB | Nov 16, 2017 |